GSK-3β has also been directly linked to several key pathological mechanisms of AD (Lovestone et al., 1994; Hong et al., 1997; Munoz-Montano et al., 1997; Liu et al., 2003; Cai et al., 2012). This evidence concerns the gene GSK3B and Alzheimer disease.